| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-10 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |